Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin)

The American Journal of Cardiology
P B BergerD R Holmes

Abstract

Little is known about the frequency of adverse events in the year following stent placement in patients treated with aspirin and ticlopidine, without warfarin. We analyzed the first such 234 consecutive patients treated at our hospital between October 1994 and December 1995. Their mean age was 62+/-12 years; 40% had had a prior myocardial infarction, 22% had undergone coronary artery bypass surgery, and 65% had multivessel disease. The indication for stent placement was dissection or abrupt closure in 24% of patients and suboptimal balloon angioplasty results in 14%; placement was elective in 62% of patients. Three hundred forty-five coronary segments were treated in the 234 patients; 305 stents (1.3 stents/patient) were placed. Palmaz-Schatz coronary stents (75%), Gianturco-Roubin stents (21%), and Johnson & Johnson biliary stents (4%) were used. Mean nominal stent size was 3.4+/-0.4 mm. High-pressure inflations (> or = 14 atm, mean 17+/-2) were performed in all patients. The mean residual stenosis was 3+/-5% by visual estimate. Intravascular ultrasound was utilized to facilitate stent placement in 53% of patients. Mean follow-up was 1.6+/-0.5 years. There were no deaths, Q-wave myocardial infarctions, coronary artery bypass o...Continue Reading

References

Oct 1, 1994·Journal of the American College of Cardiology·S L GoldbergJ M Tobis
May 1, 1994·Circulation·S NakamuraJ M Tobis

❮ Previous
Next ❯

Citations

Mar 14, 2008·The International Journal of Cardiovascular Imaging·Dae-Weung KimJin-Won Jeong
Nov 11, 1999·Clinical Cardiology·J M Wilson, J J Ferguson
Apr 2, 2004·International Journal of Clinical Practice·D J BetteridgeM Pye
Mar 25, 2000·Journal of the American College of Cardiology·S H WilsonD R Holmes
Nov 14, 2000·The American Journal of Cardiology·J L VelianouD R Holmes
Jun 3, 2014·Expert Review of Clinical Pharmacology·James P HowardAndrew Wragg
Dec 10, 2002·International Journal of Cardiovascular Interventions·Gail RichardsonMartin T Rothman
Nov 1, 2001·The Cochrane Database of Systematic Reviews·B CosmiM Milandri
Oct 12, 1999·Circulation·M J Quinn, D J Fitzgerald
Jun 29, 2001·Coronary Artery Disease·C CafriR Ilia
Sep 2, 1999·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·W W SuhK N Garratt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.